Bausch Health Companies BHC
NYSE BHC
$6.45 +0.03 (+0.55%)
As of: Oct 21, 2026 · 3:59 PM EDT

Bausch Health Companies (BHC) Liabilities and Shareholders Equity (2009 - 2026)

Updated

Bausch Health Companies' Liabilities and Shareholders Equity was $24.79 billion in Q2 2026, down 9.1% from $27.27 billion a year earlier but up 1.2% from the prior quarter.

Analysis

Bausch Health Companies (BHC) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

At the end of FY2025, Liabilities and Shareholders Equity at Bausch Health Companies came in at $26.37 billion, down 0.6% from FY2024.

  • Liabilities and Shareholders Equity shows a five-year compound annual growth rate of -3.3% (FY2020 to FY2025).
  • In earlier years, Liabilities and Shareholders Equity was $26.52 billion in FY2024 (-3.0%), $27.35 billion in FY2023 (+6.5%), $25.69 billion in FY2022 (-12.0%) and $29.2 billion in FY2021 (-6.4%).
  • Quarterly Liabilities and Shareholders Equity has moved between $24.5 billion (Q1 2026) and $29.25 billion (Q3 2021) over five years.
  • Compared with a year earlier, Liabilities and Shareholders Equity has declined for three straight quarters, with an average decline of 2.5% over the last eight quarters.
  • The best year-over-year quarter for Liabilities and Shareholders Equity over five years was Q4 2023 (growth of 6.5%); the worst was Q1 2023 (a decline of 12.5%).
  • Per Business Quant data, BHC's Liabilities and Shareholders Equity in the three quarters before Q2 2026 was $24.5 billion (Q1 2026), $26.37 billion (Q4 2025) and $26.82 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 201.06 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 135.12 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 115.83 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 49.36 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 201.13 Bn
10 Bausch Health Companies 2.42 Bn -3.32 Bn 2.08 Bn 24.79 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24.79 Bn
Mar 31, 2026 24.50 Bn
Dec 31, 2025 26.37 Bn
Sep 30, 2025 26.82 Bn
Jun 30, 2025 27.27 Bn
Mar 31, 2025 26.42 Bn
Dec 31, 2024 26.52 Bn
Sep 30, 2024 26.54 Bn
Jun 30, 2024 26.50 Bn
Mar 31, 2024 26.91 Bn
Dec 31, 2023 27.35 Bn
Sep 30, 2023 27.06 Bn
Jun 30, 2023 25.50 Bn
Mar 31, 2023 25.45 Bn
Dec 31, 2022 25.69 Bn
Sep 30, 2022 26.30 Bn
Jun 30, 2022 28.17 Bn
Mar 31, 2022 29.09 Bn
Dec 31, 2021 29.20 Bn
Sep 30, 2021 29.25 Bn
API Access

Bausch Health Companies Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=BHC&period=max&api_key=YOUR_API_KEY